TheEdgeResearch
Home / Stocks / NEXR

Nexera Technologies Ltd (NEXR)

NASDAQ Healthcare Biotechnology
$2.67 ▼ -8.56%
Market Cap
$158,521
Sector
Healthcare
Industry
Biotechnology
Beta
1.66
52-Wk Range
2.32-1106.182
CEO
Eliyahu Zamir
Country
IL
Currency
USD

Nexera Technologies Ltd operates in the Biotechnology industry of the Healthcare sector, headquartered in Bnei Brak, TA, IL. The stock last traded at $2.67, down 8.56% on the session, giving a market capitalisation of $158,521. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of -21.8%. Its beta of 1.66 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.01
Price / Sales
0.01
Price / Book
0.06
EV / EBITDA
-0.63
Gross margin
3.4%
Operating margin
-43.9%
Net margin
-21.8%
Return on equity
Debt / equity
0.47
Current ratio
1.82
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
38
IPO date
2022-08-26
Headquarters
Bnei Brak, TA, IL
About Nexera Technologies Ltd

Nexera Technologies Ltd. operates as an e-commerce enterprise primarily focused on consumer goods. The company serves as a holding entity for three distinct online retail subsidiaries—Smart Repair Pro, Purex Corp. (known as Purex), and Top Rank Ltd (referred to as Top Rank). These subsidiaries manage web stores that market a diverse array of consumer products exclusively through the Amazon online marketplace, leveraging Amazon's Fulfillment by Amazon (FBA) service for logistics. Viki Hakmon established Nexera Technologies on March 7, 2021, and its headquarters are situated in Bnei Braq, Israel.

More research on NEXR
NEXR technical analysis NEXR TheEdge Score Compare against peers
Open full interactive analysis & DCF →